Abstract:The pharmacokinetic analysis of plasma concentration--time curves after a single i.v. dose of 20 mg/kg sulphatroxazole (STZ) to calves and cows revealed a small distribution volume of STZ (mean VD(area) = 0.22-0.26 l/kg) and an age dependent elimination (mean t1/2 6.6-18.8 h). In calves and cows, STZ was extensively metabolized into the N4-acetyl and 5-hydroxy derivatives. In the plasma of calves, the N4-acetyl metabolite (N4-STZ) was present in greater amounts than the hydroxy metabolite (5-OH-STZ), while in … Show more
“…In our study, V ss did not differ significantly among different age groups, which is in agreement with the results obtained by Nouws et al (1989) in calves of 12 and 18 weeks old.…”
Section: Discussionsupporting
confidence: 95%
“…Non-ionized drugs and those with good lipid solubility, pass in either direction across rumen epithelium by a passive diffusion mechanism (Atef et al 1981;Pulido et al 1998). Nouws et al (1989) administered sulfamethazine in ruminants of two different ages (twelve and eighteen weeks-old) and they observed a longer persistence of sulphadimidine at eighteen weeks-old compared to the twelve weeks-old calves (a lower total body clearance and a prolonged elimination of this drug were found in the older animals). These authors attribute this behaviour to significant reduction in sulphadimidine hydroxylation in the older calves.…”
Sulphonamides are still being used widely, influenced by the low cost and the efficacy against many common bacterial infections, since they present a broad spectrum of activity. The aim of this study was to determine the effect of age on the pharmacokinetic/pharmacodynamics (PK/PD) integration of intravenous sulfamethazine (60 mg/kgbw) in cattle, and the possible therapeutic outcomes. Six healthy female calves, at the age of one, three, seven and fifteen weeks were used. Normality analysis was assessed with the Shapiro-Wilk test. Non-parametric tests for paired data were used. Plasma concentrations were quantified using HPLC/uv. Differences were found between one-three-weeks-old calves and seven-fifteen-weeks-old calves, in pharmacokinetic parameters (clearance, area under the concentration-time curve and elimination half-life) and in the PK/PD integration. The ratios obtained in PK/PD integration (T>MIC, WAUC) confirm that it is necessary to apply twice the dose of sulfamethazine in > or = 7 weeks-old cattle to reach a satisfactory dosage regimen (MIC > or = 32 microg/mL).
“…In our study, V ss did not differ significantly among different age groups, which is in agreement with the results obtained by Nouws et al (1989) in calves of 12 and 18 weeks old.…”
Section: Discussionsupporting
confidence: 95%
“…Non-ionized drugs and those with good lipid solubility, pass in either direction across rumen epithelium by a passive diffusion mechanism (Atef et al 1981;Pulido et al 1998). Nouws et al (1989) administered sulfamethazine in ruminants of two different ages (twelve and eighteen weeks-old) and they observed a longer persistence of sulphadimidine at eighteen weeks-old compared to the twelve weeks-old calves (a lower total body clearance and a prolonged elimination of this drug were found in the older animals). These authors attribute this behaviour to significant reduction in sulphadimidine hydroxylation in the older calves.…”
Sulphonamides are still being used widely, influenced by the low cost and the efficacy against many common bacterial infections, since they present a broad spectrum of activity. The aim of this study was to determine the effect of age on the pharmacokinetic/pharmacodynamics (PK/PD) integration of intravenous sulfamethazine (60 mg/kgbw) in cattle, and the possible therapeutic outcomes. Six healthy female calves, at the age of one, three, seven and fifteen weeks were used. Normality analysis was assessed with the Shapiro-Wilk test. Non-parametric tests for paired data were used. Plasma concentrations were quantified using HPLC/uv. Differences were found between one-three-weeks-old calves and seven-fifteen-weeks-old calves, in pharmacokinetic parameters (clearance, area under the concentration-time curve and elimination half-life) and in the PK/PD integration. The ratios obtained in PK/PD integration (T>MIC, WAUC) confirm that it is necessary to apply twice the dose of sulfamethazine in > or = 7 weeks-old cattle to reach a satisfactory dosage regimen (MIC > or = 32 microg/mL).
“…The absence of hydroxylation of SMZ in ruminants is in sharp contrast to the extensive hydroxylation of sulphatroxazole and the pyrimidine sulphonamides (like sulphadimidine, sulphamerazine, sulphadiazine) in these animals (9,10). In cows sulphatroxazole is hydroxylated and acetylated to the same extent (10).…”
Section: Metabolismmentioning
confidence: 82%
“…In cows sulphatroxazole is hydroxylated and acetylated to the same extent (10). Sulphamethoxazole and sulphatroxazole differ only in a methyl substituent at the 4 position of the oxazoyl side chain.…”
Section: Metabolismmentioning
confidence: 99%
“…Blood (and milk) sampling occurred during 48 h and urine sampling during 12 h. SMZ and its metabolites 5-hydroxy-(SOH) and Neacetylsulphamethazole (N4-synthesised by Dr. Vree as described previously (14). Protein-binding studies and deglucuronidation of samples were carried out as described in earlier papers (9,10) The plasma sulphamethoxazole (SMZ) concentration-time curves could be * Plasma percentage of N4-SMZ versus SMZ in the final elimination phase analysed according to a two-compartment model. In newborn calves the total body clearance (C1B) was less than in adults (30-50%).…”
SUMMARY The kinetics of sulphamethoxazole (SMZ) in plasma and milk, and its metabolism, protein binding and renal clearance were studied in three newborn calves and two dairy cows after intravenous administration. SMZ was predominantly acetylated; no hydroxy and glucuronide derivatives could be detected in plasma and urine. Age-dependent pharmacokinetics and metabolism of SMZ were observed. The plasma concentration-time curves of the N4-acetyl metabolite in the elimination phase were parallel to those of the parent drug; the No-acetyl metabolite plasma percentage depended on age and ranged between 100% (new-born) to 24.5% (cow). SMZ was rapidly eliminated (elimination half-lives: 2.0-4.7 It) and exhibited a relatively small distribution volume ( f/Darea: 0.44-0.571/kg). SMZ was excreted predominantly by glomerular filtration, while its No-acetyl metabolite was actively eliminated by tubular secretion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.